Where this storyline stands
A 2024 state law reclassified misoprostol and mifepristone as controlled substances. That affects how hospitals can access the drugs in non-abortion emergencies, and other states appear to be taking note.
Complete chronological journey
Every chapter below is ordered by its exact event time, from the earliest connected report to the newest development.
- 01How it started01 — How it started
Abortion Drug Law in Louisiana Heightens Hemorrhage Risk for Pregnant Patients
What happened
A 2024 state law reclassified misoprostol and mifepristone as controlled substances. That affects how hospitals can access the drugs in non-abortion emergencies, and other states appear to be taking note. Abortion Drug Law in Louisiana Heightens Hemorrhage Risk for Pregnant Patients
Why it matters
The development may affect how technology is built, regulated or used. The practical impact depends on technical details, availability and independent evaluation.